Rey F, Barré-Sinoussi F, Schmidtmayerova H, Chermann J C
Viral Oncology Unit, Institut Pasteur, Paris, France.
J Virol Methods. 1987 Jun;16(3):239-49. doi: 10.1016/0166-0934(87)90008-5.
An assay for determining neutralizing antibodies in sera from individuals infected with HIV was developed. This assay is based on an inhibition of the cytopathic effect observed after HIV superinfection of the HTLV-1-positive cell-line MT4. Only about 10% of asymptomatic seropositive donors exhibit a high titre over 1/500 up to 1/2000 while in 60% of sera, neutralizing antibodies were not detected. The assay reported here can also be used for the comparison of the biological properties of the different strains of HIV.
开发了一种用于测定感染HIV个体血清中中和抗体的检测方法。该检测方法基于对HTLV-1阳性细胞系MT4进行HIV重复感染后观察到的细胞病变效应的抑制。只有约10%的无症状血清阳性供体表现出高于1/500至1/2000的高滴度,而在60%的血清中未检测到中和抗体。本文报道的检测方法也可用于比较不同HIV毒株的生物学特性。